Search Results - "MARTINUZZO, M. E"

Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies by Forastiero, R R, Martinuzzo, M E, de Larrañaga, G F

“…The antiphospholipid syndrome (APS) is characterized by the presence of antiphospholipid antibodies (aPL) in patients with thromboembolic complications. In…”
Get full text

Frequent False-positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin by Martinuzzo, M. E., Barrera, L. H., D 'Adamo, M. A., Otaso, J. C., Gimenez, M. I., Oyhamburu, J.

“…Summary Introduction Oral direct thrombin and Xa inhibitors are worldwide distributed for prevention and treatment of thrombosis. It is important to recognize…”
Get full text

The haemostasis traffic light: a pragmatic tool for bleeding management by Mileo, F. G., Kataife, E. D., Adrover, A., Garcia Fornari, G., Lopez, M. S., Martinuzzo, M. E.

Get full text

Variability of cut‐off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study by Tripodi, A., Chantarangkul, V., Cini, M., Devreese, K., Dlott, J. S, Giacomello, R., Gray, E., Legnani, C., Martinuzzo, M. E., Pradella, P., Siegemund, A., Subramanian, S., Suchon, P., Testa, S.

“…Essentials Between‐lab variations of cut‐off values in lupus anticoagulant detection are unknown. Cut‐off values were calculated in 11 labs each testing plasma…”
Get full text

The fibrinogen prothrombin time‐derived method is not useful in patients anticoagulated with low molecular weight heparins or rivaroxaban by Duboscq, C., Martinuzzo, M. E., Ceresetto, J., Lopez, M., Barrera, L., Oyhamburu, J., Stemmelin, G.

“…Essentials Fibrinogen prothrombin time‐derived (FIBPT‐d) behavior in anticoagulated patients is under studied. FIBPT‐d method overestimates fibrinogen in…”
Get full text

High titers of autoantibodies to tissue factor pathway inhibitor are associated with the antiphospholipid syndrome by Forastiero, R. R., Martinuzzo, M. E., Broze, G. J.

“…As the activity of the tissue factor pathway inhibitor (TFPI) may be impaired in patients with antiphospholipid antibodies (aPL), 162 aPL patients were…”
Get full text

Management of factor XI deficiency in oncological liver and colorectal surgery by therapeutic plasma exchange: A case report by Burgos Pratx, L.D., Santoro, D.M., Mileo, F.G., Martinuzzo, M.E., Ardiles, V., de Santibañes, E., Salamone, H.J.

“…Factor XI (FXI) deficiency is a rare congenital hemostatic disorder associated with increased bleeding tendency in trauma, surgery or when other hemostatic…”
Get full text

Autoimmune antiphospholipid antibodies impair the inhibition of activated factor X by protein Z/protein Z‐dependent protease inhibitor by Forastiero, R. R., Martinuzzo, M. E., Lu, L., Broze, G. J.

“…The hemostatic process is tightly regulated by several antithrombotic mechanisms. Among them, protein Z (PZ)‐dependent protease inhibitor (ZPI) potently…”
Get full text

Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation by Martinuzzo, M E, Maclouf, J, Carreras, L O, Lévy-Toledano, S

“…In a group of 6 patients with lupus anticoagulant (LA) and antiphospholipid (aPL) antibodies detected by ELISA overnight urine and blood were simultaneously…”
Get more information

Thrombophilic factors in chronic thromboembolic pulmonary hypertension by Colorio, C C, Martinuzzo, M E, Forastiero, R R, Pombo, G, Adamczuk, Y, Carreras, L O

“…Chronic thromboembolic pulmonary hypertension (CTE-PH) is an infrequent cause of pulmonary hypertension that develops in 0.1–0.2% of patients who survive after…”
Get full text

False‐positive lupus anticoagulant results by DRVVT in the presence of rivaroxaban even at low plasma concentrations by Martinuzzo, M. E., Forastiero, R., Duboscq, C., Barrera, L. H., López, M. S., Ceresetto, J., Penchasky, D., Oyhamburu, J.

Get full text

Central retinal vein occlusion and thrombophilia risk factors by Adamczuk, Y P, Iglesias Varela, M L, Martinuzzo, M E, Cerrato, G S, Forastiero, R R

“…The purpose of the present study was to investigate the role of risk factors predisposing to thrombosis in patients with central retinal vein occlusion (CRVO)…”
Get full text

Binding properties of antibodies to prothrombin and β2‐glycoprotein I (β2‐GPI) assayed by ELISA and dot blot by FORASTIERO, R. R, MARTINUZZO, M. E, CARRERAS, L. O

“…Most anti‐phospholipid antibodies (aPL) associated with the anti‐phospholipid syndrome are autoantibodies with specificity towards β2‐GPI (anti‐β2‐GPI) or…”
Get full text

Influence of three types of automated coagulometers on the international sensitivity index (ISI) of rabbit, human, and recombinant human tissue factor preparations--a multicenter study by van den Besselaar, A M, Houbouyan, L L, Aillaud, M F, Denson, K W, Johnston, M, Kitchen, S, Lindahl, T L, Marren, M, Martinuzzo, M E, Droullé, C, Tripodi, A, Vergnes, C

“…Five tissue factor reagents and three types of automated instruments for prothrombin time (PT) determination were studied in an international multicenter…”
Get more information

High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity by de Larrañaga, G F, Forastiero, R R, Martinuzzo, M E, Carreras, L O, Tsariktsian, G, Sturno, M M, Alonso, B S

“…Antiphospholipid antibodies (aPL) have been reported not only in autoimmune disorders but also in various infectious diseases. Accumulating evidence indicates…”
Get full text

Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies by Martinuzzo, Marta E., Forastiero, Ricardo R., Kordich, Lucía, Carreras, Luis O.

“…Recent studies have shown that patients with antiphospholipid antibodies (aPL) have increased lipid peroxidation. We evaluated the urinary excretion of…”
Get full text

New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests by MARTINUZZO, M. E., CERRATO, G. S., VARELA, M. L. I., ADAMCZUK, Y. P., FORASTIERO, R. R.

“…Summary Introduction:  The updated guidelines for lupus anticoagulant (LA) diagnosis indicate locally calculate the cut‐off values of the index of circulating…”
Get full text

Antibodies to tissue factor pathway inhibitor are uncommonly detected in patients with infection‐related antiphospholipid antibodies by Forastiero, R. R., Martinuzzo, M. E., De Larrañaga, G., Broze, G. J.

Get full text

Multicenter evaluation of lyophilized and deep-frozen plasmas for assignment of the International Normalized Ratio by van den Besselaar, A M, Houbouyan-Reveillard, L L, Aillaud, M F, Denson, K W, Droullé, C, Johnston, M, Kitchen, S, Lindahl, T L, Marren, M, Martinuzzo, M E, Tripodi, A, Vergnes, C

“…The interlaboratory variation of the International Normalized Ratio (INR) in various external quality assessment schemes is still relatively high. This is…”
Get more information

Link between anti-CD36 antibodies and thrombosis in the antiphospholipid syndrome by PELEGRI, Y, CERRATO, G, MARTINUZZO, M. E, CARRERAS, L. O, FORASTIERO, R. R

“…Some studies have previously suggested the involvement of antibodies directed against CD36 (anti-CD36) in the pathogenesis of thrombosis. The aim of this study…”
Get full text